Gabelli Funds LLC Lexicon Pharmaceuticals, Inc. Transaction History

Gabelli Funds LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$5.35 - $7.11 $53,500 - $71,100	-10,000 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$4.36 - $7.94 $43,600 - $79,400	-10,000 Reduced 50.0%	10,000 $56,000
Q3 2018 Nov 02, 2018	BUY	$10.32 - $13.06 $10,320 - $13,060	1,000 Added 5.26%	20,000 $213,000
Q2 2018 Aug 10, 2018	BUY	$7.8 - $13.69 $10,920 - $19,166	1,400 Added 7.95%	19,000 $228,000
Q3 2017 Nov 01, 2017	BUY	$12.17 - $16.3 $214,192 - $286,880	17,600	17,600 $216,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.